Related Experiment Video
Updated: Jun 8, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2
Wei Sun1, Wenwen Shen, Shuang Yang
1Laboratory of Molecular Genetics, College of Medicine, Nankai University, Tianjin 300071, China.
Abstract:
miR-142 and miR-223 have been identified as hematopoietic specific microRNAs. miR-223 has crucial functions in myeloid lineage development. However, the function of miR-142 remains unclear. In this study, we found that both miR-142 and miR-223 attenuated the proliferation of hematopoietic cells, and that miR-223 up-regulated miR-142 expression through the LMO2-L/-S isoforms and CEBP-β. miR-223 negatively regulated both LMO2-L/-S isoforms and CEBP-β post-transcriptionally, while CEBP-β positively regulated the LMO2-L/-S isoforms and both of the LMO2-L/-S isoforms negatively regulated miR-142. These results reveal a novel miR-223--CEBP-β--LMO2--miR-142 regulatory pathway, which has pivotal functions in hematopoiesis.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Regulation of Hematopoietic Stem Cells
Negative Regulator Molecules
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

